

30 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264482/37149/en/PDS-Biotech-Reports-Full-Year-2025-Financial-Results-and-Provides-Update-on-PDS0101-Phase-3-Program-and-PDS01ADC-Clinical-Advancement.html

22 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/22/3223777/37149/en/PDS-Biotech-Announces-New-U-S-Patent-Covering-Technology-Underlying-PDS0101.html

09 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/09/3216091/37149/en/PDS-Biotech-Announces-FDA-Alignment-on-use-of-Progression-Free-Survival-PFS-as-Primary-Endpoint.html

09 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/09/3202308/37149/en/PDS-Biotech-Announces-New-Composition-of-Matter-Patent-for-PDS0101-in-Japan.html

02 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/02/3197934/37149/en/PDS-Biotech-Announces-Scheduling-of-Type-C-Meeting-with-U-S-Food-and-Drug-Administration-FDA.html

13 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/13/3187197/37149/en/PDS-Biotech-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Clinical-Programs-Update.html